Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

NEXT STORY
AnaptysBio Announces Agreement to Monetize Portion of JEMPERLI Royalties for $250 Million with Sagard
PREV STORY
Brandywine Realty Trust Announces Third Quarter 2021 Results and Narrows 2021 Guidance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ADMA Biologics Reports First Quarter 2018 Financial Results

Key Manufacturing Milestones Achieved During First QuarterRAMSEY, N.J. and BOCA RATON, Fla., May 14, ...

author_avatar
NASDAQ Market News

Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

author_avatar
NASDAQ Market News

G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

author_avatar
NASDAQ Market News